Publication: The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
Date
Authors
Sözer, Selçuk
Authors
Fiel, Maria Isabel
Schiano, Thomas
Xu, Mingjiang
Mascarenhas, John
Hoffman, Ronald
Advisor
Language
Type
Publisher:
American Society of Hematology
Journal Title
Journal ISSN
Volume Title
Abstract
Patients with myeloproliferative disorders are at a high risk of developing thrombotic events. Several investigators have hypothesized that endothelial cell (EC) abnormalities might contribute to this prothrombotic state. Budd-Chiari syndrome (BCS) and portal vein thrombosis have been reported to be associated with JAK2V617F-positive hematopoiesis. We explored whether JAK2V617F was present in ECs in the vessels of polycythemia vera (PV) patients with BCS using laser capture microdissection followed by nested polymerase chain reaction or reverse-transcribed polymerase chain reaction. The ECs of the 2 BCS patients with PV were homozygous for the JAK2V617F and were shown to express transcripts characteristic of ECs but not hematopoietic cells. ECs of the other BCS patient with PV and 2 patients with hepatoportal sclerosis without PV contained exclusively wild-type JAK2. The presence of JAK2V617F in both ECs and hematopoietic cells belonging to BCS patients with PV indicate that ECs in PV are involved by the malignant process and that in a subpopulation of the patients the disease might originate from a common cell of origin for hematopoietic and ECs.
Description
Source:
Keywords:
Keywords
Progenitor cells, Polycythemia-vera, Stem-cell, Jak2, V617f, Hemangioblast, Hematology
Citation
Sözer, S. vd. (2009). "The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome". Blood, 113(21), 5246-5249.